This transgene consists of the human Prkag2 cDNA, with a point mutation altering arginine 531 to glycine, under the control of the cardiac-specific alpha-myosin heavy chain promoter. Western blot analysis of heart lysates confirmed that protein expression is restricted to the heart. (J:108517)